ArticleProceedings of the National Academy of Sciences of the United States of America2016

Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.

Stefanie N Linch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.